Vision is the mantra of entrepreneurs.
Dr. Craig Shimasaki, president and CEO of Moleculera Labs Inc., serial entrepreneur and adviser to multiple teams in Oklahoma's collegiate business plan competition, the Governor's Cup, says vision begins with the way we look at the world.
“Everything we see that is man-made existed in the mind of someone before it ever came into being,” he said. “The challenge is to encourage, teach and inspire young entrepreneurs to think differently about what they see in the world around them, seeing solutions that connect to a problem.”
Recently, Shimasaki advised two Governor's Cup teams from Oklahoma City University, including one that wrote a business plan around his company's concept. Moleculera Labs won first place in the Undergraduate Division; Precision HealthTech placed third in the Graduate Division.
“I like helping the students understand that they don't have to be expert at everything,” he said. “They have initiative, motivation and drive. What they need are guidelines, insight, experience and a little help.”
Moleculera Labs recently received a syndicated investment of more than $500,000 to create a scalable lab test to predict a patient's likelihood of having Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococci (PANDAS), a form of autism spectrum disorder.
Moleculera Labs' vision is to make this test readily available to identify the origin of a child's disorder so the child can receive treatment that can reduce the symptoms, allowing the child to better function in society. He estimates Moleculera Labs will have a testing lab operational within the next six months.